Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactThe cancer stem cell: evidence for its origin as an injured autoreactive T cellHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Extrahepatic manifestations of chronic hepatitis C virus infectionInfectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective TherapyHepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy optionsBenign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus InfectionHepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral TherapyRelationships between lymphomas linked to hepatitis C virus infection and their microenvironmentEffect of hepatitis C virus core protein on the molecular profiling of human B lymphocytesAnalysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated ControlsHepatitis C virus and lymphomaClonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaAntibody-Dependent Enhancement of Hepatitis C Virus InfectionHepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope ProteinHost-Microbiome Interaction and Cancer: Potential Application in Precision MedicineAntiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaThe expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma.Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphomaSomatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemiaHepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagementPathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.Secondary cutaneous marginal zone B-cell lymphoma presenting as lipoatrophy in a patient with hepatitis CReview.Hepatitis C virus-related lymphoproliferative disorders: an overview.Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.Lymphoid malignancies: the dark side of B-cell differentiation.microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virusB-cell receptor signaling as a driver of lymphoma development and evolution.Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Human viruses and cancer.Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphomaThe lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemiaPrimary spleen lymphoma associated with hepatitis C virus infection
P2860
Q22299128-6D21B31B-297E-4D63-82A9-5172A172C4DFQ25256839-607CEDC4-F18C-4804-A887-84B7C832F638Q26750997-41D6C493-D7D7-45FC-B5EB-3EB2A63A3C4CQ26767084-3806F3A6-C56F-4593-A477-2D172394F4F5Q26770344-01CEE92D-1302-426F-9373-F5926AC4F98BQ26775007-D5603F1D-9BCE-42DB-AA0A-CCCE6205F74AQ26775733-0EC4783B-F99B-40E3-80BF-01B7E7E89792Q26781743-ACBC4FA6-83BB-40C1-B578-DBCDF9CCFDF3Q27023448-0AC28AED-3CFC-40C2-A2C8-42E65BB21BD2Q27473390-E40992A0-6054-4568-8FD5-01B3D941B2B5Q27480341-D32C9644-069D-47B5-A616-4B59BB272E47Q27482007-547100AA-2A16-4845-9013-E1E2F560CB20Q27485227-2D4708D3-E101-4318-9984-E27EE4B782C8Q27485451-E85225A1-11B9-4E94-A8FE-85A3AD1B4311Q27486411-531584C5-4F34-4759-A9D4-2FDDB1119580Q28069401-C5163DAC-B5A9-429C-A61A-89DAD2B41049Q28080160-982FB4D8-6FA8-4B6A-A247-2D73CF3B24E2Q30251847-669CFA16-DDF4-49D5-BA83-96F3B89B935FQ31154023-20BF9463-C19A-4FFE-A5E4-555AABBD4394Q33346756-8B8707B8-0719-401F-BD55-3A463F4F52A4Q33415564-ECDB57B7-799F-434A-8E0F-FC6452674A72Q33418199-DE89DC93-9105-4BCF-A01B-3702C4A57C7EQ33587826-55B9E12A-F830-484F-9429-E38B670439DDQ33634440-A9772B79-CC6E-4BD5-A71B-B3E7D3D99C8AQ33883727-808A6BB7-CB0F-4947-95AC-F34E4F43F454Q33889168-D4A738C9-F85F-43A7-875F-8C496DEBB6B9Q33890865-5CA9B5AC-02AF-4DF5-9DDE-0CBED654272AQ34062040-526B51CE-CEBF-4976-871C-D5F7B2BA9E7EQ34098553-D58CCB4A-3796-43C0-84C1-1ABA07474C18Q34102077-5AD4C04C-0E5C-4841-A035-C5779B155C09Q34162187-E385184E-042F-4F74-AC31-674D023C7EE4Q34163429-F92BE3A2-EEBD-4C52-9A13-530715183A32Q34398579-5956EC41-5FA1-4F32-9722-28E57E50190EQ34420891-67CA9E30-0C32-43B4-98D3-BF673EE370F7Q34423461-25F410C9-6D69-4E09-8B3C-2F226600B852Q34521334-A0361C7F-CA98-4BFC-AB00-0D40C5EB44BCQ34542102-69CB902F-B174-491C-B456-616DDF7C96F4Q34552105-54FB7754-DC0F-4808-B6CE-78923C3A8F94Q34708468-641F4EC1-FB40-4067-A601-2C258C897CFEQ34710617-5914486E-9F20-4C91-BCA8-3AB8E568E616
P2860
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@en
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@nl
type
label
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@en
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@nl
prefLabel
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@en
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@nl
P2093
P356
P1476
Regression of splenic lymphoma ...... f hepatitis C virus infection.
@en
P2093
Bruno Varet
Béatrice Delmas
Christian Brechot
François Lefrère
Françoise Valensi
Jean-Pierre Bronowicki
Katayoun Jondeau
Virginie Eclache-Saudreau
Xavier Mariette
Xavier Troussard
P356
10.1056/NEJMOA013376
P407
P577
2002-07-01T00:00:00Z